Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI with Oxaliplatin, Folinic Acid and 5-FU in Liver-Predominant Metastatic Colorectal Cancer
NCT02345746Phase 2Withdrawn
- Sponsor
- Western Regional Medical Center
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil in metastatic colorectal cancer (mCRC), sponsored by Western Regional Medical Center. Planned start Dec 2012; status: withdrawn.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02345746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02345746.